Dexatrenz Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Ranchi, Jharkhand, India, established in 2018.
2018 Ranchi, Jharkhand, India Active
Last Updated:
Access Report
About Dexatrenz Pharmaceutical Private Limited

Dexatrenz Pharmaceutical Private Limited, a active private limited company, was established on 20 February 2018 in Ranchi, Jharkhand, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74993JH2018PTC011004. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sumit Kumar Singh (Director), Nilu Devi (Director). Past directors included Rupika Kumari, Ridhi Deepa Das. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H/O Ramjee Singh, Lower Karam Toli Ps: Lalpur Po: Morabadi, Ranchi, Jharkhand, 834008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74993JH2018PTC011004

  • Registration Number

    011004

  • Incorporation Date

    20 February 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ranchi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Dexatrenz Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dexatrenz Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dexatrenz Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Sumit Kumar Singh Director 28 Jun 2024 Current
Nilu Devi Director 20 Feb 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Jul 2024 Past
Pramod Abcsdd Director 06 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dexatrenz Pharmaceutical.

Enhance accessibility to Dexatrenz Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dexatrenz Pharmaceutical revenue growth over time
Dexatrenz Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dexatrenz Pharmaceutical?

Unlock access to Dexatrenz Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dexatrenz Pharmaceutical?

Unlock and access historical data on people associated with Dexatrenz Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dexatrenz Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dexatrenz Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dexatrenz Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dexatrenz Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Dexatrenz Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi. was recorded as a recent event.

  • Director Appointment

    The activity Sumit Kumar Singh was appointed as a Director was appointed as a Director on 28 Jun 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Director Appointment

    Nilu Devi was appointed as a Director was appointed as a Director on 20 Feb 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Dexatrenz Pharmaceutical Private Limited was registered on 20 Feb 2018 with Roc Ranchi & aged 7 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dexatrenz Pharmaceutical Private Limited?

The CIN of Dexatrenz Pharmaceutical Private Limited is U74993JH2018PTC011004.

Where is Dexatrenz Pharmaceutical Private Limited headquartered?

Dexatrenz Pharmaceutical Private Limited is headquartered at H/O Ramjee Singh, Lower Karam Toli Ps: Lalpur Po: Morabadi, Ranchi, Jharkhand, 834008.

When was Dexatrenz Pharmaceutical Private Limited incorporated?

Dexatrenz Pharmaceutical Private Limited was incorporated on 20 February 2018.

Who are the current directors of Dexatrenz Pharmaceutical Private Limited?

The current directors of Dexatrenz Pharmaceutical Private Limited are

What is the primary industry of Dexatrenz Pharmaceutical Private Limited?

The primary industry of Dexatrenz Pharmaceutical Private Limited is Pharma.

Is Dexatrenz Pharmaceutical Private Limited a listed company?

Dexatrenz Pharmaceutical Private Limited is unlisted.

What is the capital structure of Dexatrenz Pharmaceutical Private Limited?

The authorized capital of Dexatrenz Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available